Literature DB >> 16842244

Gastric mucin phenotype defines tumour progression and prognosis of intrahepatic cholangiocarcinoma: gastric foveolar type is associated with aggressive tumour behaviour.

S Aishima1, Y Kuroda, Y Nishihara, K Taguchi, A Taketomi, Y Maehara, M Tsuneyoshi.   

Abstract

AIMS: To identify the role of mucus core protein (MUC) in intrahepatic cholangiocarcinoma (ICC). METHODS AND
RESULTS: We examined the expression profile of MUC2, MUC5AC and MUC6 by immunohistochemical staining in 100 ICCs and compared the clinicopathological factors and the immunohistochemical results. The expression frequency was: MUC2, 9%; MUC5AC, 40%; and MUC6, 21%. According to the gastric mucin expression profile, ICCs were classified into the following groups: null type (n = 43), gastric foveolar type (n = 36), pyloric gland type (n = 11) and gastric combined type (n = 10). Half of the gastric foveolar type and the gastric combined type were located in the hilar region, but the other types were predominant at the periphery (P = 0.0004). Well-differentiated components were more often detected in the gastric combined type and the pyloric gland type (P = 0.0281). The gastric foveolar type was associated with a higher incidence of lymph node metastasis (P < 0.0001). The pyloric gland type was associated with better survival and the gastric foveolar type was associated with worse survival. The gastric mucin phenotype was an independent prognostic factor by multivariate survival analysis.
CONCLUSION: The gastric foveolar type of ICC was more often associated with aggressive tumour development, whereas the pyloric gland type exhibited less aggressive behaviour.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16842244     DOI: 10.1111/j.1365-2559.2006.02414.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  14 in total

Review 1.  Emerging potential of natural products for targeting mucins for therapy against inflammation and cancer.

Authors:  Muzafar A Macha; Shiv Ram Krishn; Rahat Jahan; Kasturi Banerjee; Surinder K Batra; Maneesh Jain
Journal:  Cancer Treat Rev       Date:  2015-01-14       Impact factor: 12.111

2.  Expression of survivin, MUC2 and MUC5 in colorectal cancer and their association with clinicopathological characteristics.

Authors:  Haipeng Wang; Shengjian Jin; Huiling Lu; Sisi Mi; Wenhua Shao; Xiaoxv Zuo; Huangyi Yin; Sien Zeng; Fumio Shimamoto; Guangying Qi
Journal:  Oncol Lett       Date:  2017-05-19       Impact factor: 2.967

3.  Altered expression of MUC2 and MUC5AC in progression of colorectal carcinoma.

Authors:  Xiao-Dong Bu; Nan Li; Xiao-Qiang Tian; Li Li; Jin-Song Wang; Xiao-Jin Yu; Pei-Lin Huang
Journal:  World J Gastroenterol       Date:  2010-08-28       Impact factor: 5.742

4.  Claudin-18 in biliary neoplasms. Its significance in the classification of intrahepatic cholangiocarcinoma.

Authors:  Aya Shinozaki; Junji Shibahara; Naohiro Noda; Mariko Tanaka; Taku Aoki; Norihiro Kokudo; Masashi Fukayama
Journal:  Virchows Arch       Date:  2011-05-24       Impact factor: 4.064

5.  Expression of keratin 20 and its clinicopathological significance in intrahepatic cholangiocarcinoma.

Authors:  Ji Eun Choi; Sang Jae Noh; Ju Hyung Lee; Jun Sang Bae; Hyun Hee Chu; Ho Sung Park; Kyu Yun Jang; Myoung Ja Chung; Myoung Jae Kang; Dong Geun Lee; Woo Sung Moon
Journal:  Oncol Lett       Date:  2012-06-13       Impact factor: 2.967

6.  Advances in miRNA-Mediated Mucin Regulation.

Authors:  Shiv Ram Krishn; Surinder K Batra; Sukhwinder Kaur
Journal:  Curr Pharmacol Rep       Date:  2015-01-15

7.  MUC6 expression is a preferable prognostic marker for invasive mucinous adenocarcinoma of the lung.

Authors:  Kazuhiro Yamanoi; Chifumi Fujii; Hanae Yuzuriha; Mai Kumazawa; Masayuki Shimoda; Katsura Emoto; Hisao Asamura; Jun Nakayama
Journal:  Histochem Cell Biol       Date:  2022-03-30       Impact factor: 4.304

8.  Induction of MUC5AC mucin by conjugated bile acids in the esophagus involves the phosphatidylinositol 3-kinase/protein kinase C/activator protein-1 pathway.

Authors:  Shumei Song; James C Byrd; Sushovan Guha; Kai-Feng Liu; Dimpy Koul; Robert S Bresalier
Journal:  Cancer       Date:  2010-12-14       Impact factor: 6.860

9.  EVI1 expression is associated with aggressive behavior in intrahepatic cholangiocarcinoma.

Authors:  Mariko Tanaka; Junji Shibahara; Shumpei Ishikawa; Tetsuo Ushiku; Teppei Morikawa; Aya Shinozaki-Ushiku; Akimasa Hayashi; Kento Misumi; Atsushi Tanaka; Hiroto Katoh; Kei Sakuma; Takashi Kokudo; Yoshinori Inagaki; Junichi Arita; Yoshihiro Sakamoto; Kiyoshi Hasegawa; Masashi Fukayama
Journal:  Virchows Arch       Date:  2018-10-23       Impact factor: 4.064

10.  Prognostic Factors for Surgically Resected Intraductal Papillary Neoplasm of the Bile Duct: A Retrospective Cohort Study.

Authors:  Shuichiro Uemura; Ryota Higuchi; Takehisa Yazawa; Wataru Izumo; Yutaro Matsunaga; Masahiro Shiihara; Takehiro Ota; Toru Furukawa; Masakazu Yamamoto
Journal:  Ann Surg Oncol       Date:  2020-07-10       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.